Washington, DC— In a Friday night news dump, the Administration seems to have finally admitted to what we have already known: that the tariffs aren’t working.
Washington, DC—Rep. Ron Kind released the following statement after the Senate passed the United States Mexico Canada Agreement (USMCA):
Washington, DC—Today, Rep. Ron Kind voted to overturn Department of Education Secretary Betsy DeVos’s rewritten borrower defense rule which gutted essential protections for student borrowers and taxpayers.
Washington, DC—Today, Rep. Ron Kind released the following statement after President Trump signed the first phase of a trade deal with China:
Washington, DC— Today, Rep. Ron Kind announced his support for a War Powers Resolution, which would prevent further military escalation with Iran without authorization from Congress. This resolution comes after U.S.
Washington, DC— Reps. Ron Kind (D-WI) and Michael C. Burgess, M.D. (R-TX) recently introduced H.R. 5534, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019. This bipartisan legislation would improve coverage under Medicare for immunosuppressive drugs for kidney transplant patients.
Washington, DC—Today, Rep. Ron Kind and the House of Representatives voted to pass the United States Mexico Canada Agreement (USMCA). The agreement passed with overwhelming bipartisan support in a largely bipartisan manner.
Washington, DC—Rep. Ron Kind released the following statement after voting for the articles of impeachment against President Donald J. Trump:
Kind voted NO on fiscally irresponsible funding bill that significantly adds to our national debt
Washington, DC – Today, Rep. Ron Kind voted against the fiscally irresponsible government spending package, which includes a number of policies unrelated to funding the government, including significantly increased spending and around $500 billion in lost revenue for the Government.
Washington, DC—Today, Rep. Ron Kind voted for and the House passed H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, legislation that would lower prescription drug prices and level the playing field for American patients and taxpayers. The Elijah E. Cummings Lower Drug Costs Now Act: